{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:24:39Z","timestamp":1792160679914,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T00:00:00Z","timestamp":1562976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673359"],"award-info":[{"award-number":["81673359"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.apsb.2019.07.003","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T11:41:27Z","timestamp":1563450087000},"page":"693-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats"],"prefix":"10.1016","volume":"10","author":[{"given":"Wenhao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuchu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2019.07.003_bib1","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2019.07.003_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1039\/C4TB01611D","article-title":"Diagnostic imaging and therapeutic application of nanoparticles targeting the liver","volume":"3","author":"Wang","year":"2015","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.apsb.2019.07.003_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198409010-00001","article-title":"First-pass elimination. Basic concepts and clinical consequences","volume":"9","author":"Pond","year":"1984","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.apsb.2019.07.003_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1021\/mp060011k","article-title":"Methods to evaluate biliary excretion of drugs in humans: an updated review","volume":"3","author":"Ghibellini","year":"2006","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2019.07.003_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/SLA.0b013e31825d5d47","article-title":"Physiological and biochemical basis of clinical liver function tests","volume":"257","author":"Hoekstra","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.apsb.2019.07.003_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2011.09.098","article-title":"The journey of a drug\u2013carrier in the body: an anatomo-physiological perspective","volume":"161","author":"Bertrand","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2019.07.003_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2019.07.003_bib8","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jhep.2011.05.039","article-title":"Nanotechnology for therapy and imaging of liver diseases","volume":"55","author":"Reddy","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2019.07.003_bib9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.nantod.2010.06.007","article-title":"Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases","volume":"5","author":"Li","year":"2010","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2019.07.003_bib10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/hep.22099","article-title":"Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C","volume":"47","author":"Fontana","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2019.07.003_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccr.2010.01.018","article-title":"Obesity, inflammatory signaling, and hepatocellular carcinoma\u2014an enlarging link","volume":"17","author":"Toffanin","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2019.07.003_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1593\/neo.07781","article-title":"Tumor necrosis factor-\u03b1 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma","volume":"9","author":"Jeng","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.apsb.2019.07.003_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1478-3231.2006.01409.x","article-title":"Survival and apoptosis: a dysregulated balance in liver cancer","volume":"27","author":"Fabregat","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.apsb.2019.07.003_bib14","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.07.003_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.apsb.2015.02.003","article-title":"Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis","volume":"5","author":"Cheng","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2019.07.003_bib16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0945-053X(98)90011-7","article-title":"Expression and function of heat shock protein 47: a collagen-speci\ufb01c molecular chaperone in the endoplasmic reticulum","volume":"16","author":"Nagata","year":"1998","journal-title":"Matrix Biol"},{"key":"10.1016\/j.apsb.2019.07.003_bib17","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1016\/S0021-9258(17)41724-8","article-title":"Hsp47 and the translation-translocation machinery cooperate in the production of alpha 1(I) chains of type I procollagen","volume":"269","author":"Sauk","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.07.003_bib18","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies","volume":"328","author":"Friedman","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2019.07.003_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2019.07.003_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.apsb.2017.02.004","article-title":"Advances in ultrasound-targeted microbubble\u2013mediated gene therapy for liver fibrosis","volume":"7","author":"Huang","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2019.07.003_bib21","first-page":"S300","article-title":"Hepatic fibrosis: from bench to bedside","volume":"17 Suppl 3","author":"Schuppan","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2019.07.003_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403005684","article-title":"Molecular basis of hepatic fibrosis","volume":"5","author":"Hui","year":"2003","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.apsb.2019.07.003_bib23","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1172\/JCI66369","article-title":"Hepatic stellate cells in liver development, regeneration, and cancer","volume":"123","author":"Yin","year":"2013","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2019.07.003_bib24","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1016\/j.biomaterials.2014.04.037","article-title":"Hepatitis B virus preS1-derived lipopeptide functionalized liposomes for targeting of hepatic cells","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2019.07.003_bib25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.apsb.2018.09.001","article-title":"Theranostic nanoparticles with tumor-specific enzyme- triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment","volume":"9","author":"Liu","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2019.07.003_bib26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc1391","article-title":"Hyaluronan: from extracellular glue to pericellular cue","volume":"4","author":"Toole","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2019.07.003_bib27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/17425241003730399","article-title":"Nanostructured hyaluronic acid-based materials for active delivery to cancer","volume":"7","author":"Ossipov","year":"2010","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.apsb.2019.07.003_bib28","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1039\/b900456d","article-title":"Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in\u00a0vivo biodistribution","volume":"19","author":"Choi","year":"2009","journal-title":"J Mater Chem"},{"key":"10.1016\/j.apsb.2019.07.003_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.apsb.2017.11.005","article-title":"Biomacromolecules as carriers in drug delivery and tissue engineering","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2019.07.003_bib30","first-page":"2592","article-title":"Liposome-encapsulated doxorubicin targeted to CD44 a strategy to kill CD44-overexpressing tumor cells","volume":"61","author":"Eliaz","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2019.07.003_bib31","doi-asserted-by":"crossref","first-page":"32259","DOI":"10.1074\/jbc.M300347200","article-title":"Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells","volume":"278","author":"Sugahara","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.07.003_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.apsb.2018.11.006","article-title":"Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy","volume":"9","author":"Zhong","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2019.07.003_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biomaterials.2018.03.046","article-title":"Enzyme-triggered size shrink and laser- enhanced NO release nanoparticles for deep tumor penetration and combination therapy","volume":"168","author":"Hu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2019.07.003_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2018.04.005","article-title":"Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis","volume":"278","author":"Liu","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2019.07.003_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0169-409X(91)90006-X","article-title":"Cellular events in the uptake and degradation of hyaluronan","volume":"7","author":"Smedsrod","year":"1991","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2019.07.003_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/03008208609001971","article-title":"The catabolic fate of hyaluronic acid","volume":"15","author":"Laurent","year":"1986","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.apsb.2019.07.003_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jhep.2006.08.022","article-title":"Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis","volume":"46","author":"Warren","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2019.07.003_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ijerph14010011","article-title":"Ameliorative effect of curcumin-encapsulated hyaluronic acid-PLA nanoparticles on thioacetamide-induced murine hepatic fibrosis","volume":"14","author":"Chen","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.apsb.2019.07.003_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.apsb.2018.09.004","article-title":"Supersaturated polymeric micelles for oral silybin delivery: the role of the Soluplus\u2013PVPVA complex","volume":"9","author":"Zhu","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2019.07.003_bib40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.nano.2008.09.001","article-title":"Self-associated indisulam in phospholipid-based nanomicelles: a potential nanomedicine for cancer","volume":"5","author":"Cesur","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apsb.2019.07.003_bib41","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/jps.20150","article-title":"In\u00a0vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation","volume":"93","author":"Ashok","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.apsb.2019.07.003_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2009.09.010","article-title":"Target speci\ufb01c and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives","volume":"141","author":"Oh","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2019.07.003_bib43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jbm.a.31681","article-title":"Control of the molecular degradation of hyaluronic acid hydrogels for tissue augmentation","volume":"86A","author":"Oh","year":"2008","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.apsb.2019.07.003_bib44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1021\/mp800176t","article-title":"Target speci\ufb01c intracellular delivery of siRNA\/PEI-HA complex by receptor mediated endocytosis","volume":"6","author":"Jiang","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2019.07.003_bib45","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1021\/bc9900338","article-title":"Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate","volume":"10","author":"Luo","year":"1999","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.apsb.2019.07.003_bib46","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.biomaterials.2011.11.022","article-title":"Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel","volume":"33","author":"Li","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2019.07.003_bib47","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s11095-013-1225-y","article-title":"Multifunctional tumor-targeting nanoparticles based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel","volume":"31","author":"Song","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2019.07.003_bib48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2016.01.049","article-title":"Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy","volume":"225","author":"Li","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2019.07.003_bib49","first-page":"274","article-title":"The preparation and purification of silybin meglumine","volume":"26","author":"Zhang","year":"2008","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.apsb.2019.07.003_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijpharm.2013.06.053","article-title":"Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS","volume":"454","author":"Xu","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2019.07.003_bib51","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1158\/0008-5472.CAN-09-0096","article-title":"Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study","volume":"69","author":"Raina","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2019.07.003_bib52","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2019.07.003_bib53","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1021\/nn100589y","article-title":"Bioimaging for targeted delivery of hyaluronic acid derivatives to the livers in cirrhotic mice using quantum dots","volume":"4","author":"Kim","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2019.07.003_bib54","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2019.07.003_bib55","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1021\/mp500637b","article-title":"Co-encapsulated doxorubicin and bromotetrandrine lipid nanoemulsions in reversing multidrug resistance in breast cancer in\u00a0vitro and in\u00a0vivo","volume":"12","author":"Cao","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2019.07.003_bib56","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbrc.2007.12.171","article-title":"Continuous high expression of XBP1 and GRP78 is important for the survival of bone marrow cells in CCl4-treated cirrhotic liver","volume":"367","author":"Marumoto","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2019.07.003_bib57","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1021\/mp400303w","article-title":"Novel lipid hybrid albumin nanoparticle greatly lowered toxicity of pirarubicin","volume":"10","author":"Zhou","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2019.07.003_bib58","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3109\/10717544.2014.936988","article-title":"Development, characterization and toxicological evaluations of phospholipids complexes of curcumin for effective drug delivery in cancer chemotherapy","volume":"23","author":"Khatik","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2019.07.003_bib59","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1016\/j.biomaterials.2014.01.018","article-title":"Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin","volume":"35","author":"Li","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2019.07.003_bib60","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2012.02.011","article-title":"Drug targeting to the diseased liver","volume":"161","author":"Poelstra","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2019.07.003_bib61","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1023\/A:1015318415705","article-title":"Massive and selective delivery of lipid-coated cationic lipoplexes of oligonucleotides targeted in\u00a0vivo to hepatic endothelial cells","volume":"19","author":"Bartsch","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2019.07.003_bib62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/aps.2010.192","article-title":"Mixed micelles loaded with silybin-polyene phosphatidylcholine complex improve drug solubility","volume":"32","author":"Duan","year":"2011","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.apsb.2019.07.003_bib63","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1039\/c2sm25456e","article-title":"Reduction-responsive shell-crosslinked micelles prepared from Y-shaped amphiphilic block copolymers as a drug carrier","volume":"8","author":"Yue","year":"2012","journal-title":"Soft Matter"},{"key":"10.1016\/j.apsb.2019.07.003_bib64","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1021\/bc2003499","article-title":"Synthesis and characterization of biodegradable and thermosensitive polymeric micelles with covalently bound doxorubicin-glucuronide prodrug via click chemistry","volume":"22","author":"Talelli","year":"2011","journal-title":"Bioconjug Chem"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383519300553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383519300553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:43:42Z","timestamp":1761929022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383519300553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2211383519300553"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2019.07.003","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2019.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}